Speaking of Sinopharm Holdings, the leading company in China's pharmaceutical industry, you will think of Wei Yulin. Resolute in career and approachable in life, this is the accurate description of Wei Yulin.

In 2003, Wei Yulin joined Sinopharm Holdings and is currently the company's chairman. During his tenure as president, Sinopharm's sales scale, business network, and position in the pharmaceutical industry have all developed greatly.

Wei Yulin's career success is inseparable from his educational experience. He has studied business enterprise management, and further studied the PE Investment and Financing Program for China CEO (13th) of Antai College of Economics and Management, Shanghai Jiaotong University.

In this article, we will mainly talk about Wei Yulin's successful career and the help of Antai College to his career.

Overview of the career

The best strategy in business is to turn opponents into alliances. It is difficult to achieve effective integration in an industry with the disorderly competition. However, Wei Yulin led Sinopharm to implement the industrial integration strategy successfully.

In January 2003, Sinopharm Holding Co., Ltd. was established, and Wei Yulin was the deputy general manager of the company.

In 2006, he served as the chief operating officer of the company. Wei Yulin took the company's listing for equity financing, broke the development bottleneck, integrated the business operation platform, and built the headquarters structure.

In 2009, the company was listed in Hong Kong and successfully raised US$1.2 billion. This financing is one of the most successful financing projects in the pharmaceutical industry after the global financial crisis in 2008.

After the company went public, Wei Yulin took over the position as the company's president. His goal is to make the company an industry leader and remain dominant.

Sinopharm currently has 51 distribution centers across the country, covering nearly 94% of tertiary hospitals and more than 50% of secondary hospitals, with sales exceeding 166 billion yuan.

Ultimately, he made the company a recognized leader in the pharmaceutical distribution industry in China.

Wei Yulin and Antai College

"I am very fortunate to have chosen to study at Jiaotong University, and I have gained more than I expected here."

Wei Yulin believes that business school study has a profound impact on the development of enterprises and individuals. Years of practical and management experience made him understand the importance of updating the knowledge structure.

During his study in the PE Investment and Financing Program for China CEO at Antai College, Wei Yulin believed that the chairman of the 100 billion-asset company needs to know more about the operation of financial assets and private equity.

Why choose Antai College of Economics and Management, Shanghai Jiaotong University?

Wei Yulin said that Sinopharm Holding has always cooperated with Jiaotong University.

"We have always required the managers of the various company and the middle-level cadres of the headquarters to have MBA and EMBA degrees. In this regard, we have the most cooperation with Jiaotong University."

"The course design of Antai College's PE Investment and Financing Program for China CEO is more practical, with both theoretical research and practical operations. In addition, the research content is also closely related to the current market."

Wei Yulin represented that the role played by Jiaotong University in leading the transformation and upgrading of enterprises is greatly valuable. The study at the business school had also given managers a new understanding of industry trends.

On the other hand, Wei Yulin said that Jiaotong University had given the students precious friendship and alumni network.

"Everyone listed the problems they encountered in work to discuss with classmates, shared learning and training information, and participated in various extracurricular activities, which enhanced friendship and gained more life experience. "

During Wei Yulin's study at Jiaotong University, he was more clear about the industry's future trend and strengthened the company's future development direction.